Cargando…
Developmental Evaluation of Infants Who Have Received Tadalafil in Utero for Fetal Growth Restriction
To assess the long-term effects of tadalafil, a therapeutic agent for fetal growth restriction (FGR), we evaluated the developmental progress of 1.5-year-old infants whose mothers had taken tadalafil during pregnancy. Twenty-four infants were assessed. We evaluated infant body weight, height, and he...
Autores principales: | Maki, Shintaro, Kato, Ineko, Enomoto, Naosuke, Takakura, Sho, Nii, Masafumi, Tanaka, Kayo, Tanaka, Hiroaki, Hori, Shinsuke, Matsuda, Kana, Ueda, Yukito, Sawada, Hirofumi, Hirayama, Masahiro, Sudo, Akihiro, Ikeda, Tomoaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291198/ https://www.ncbi.nlm.nih.gov/pubmed/32413997 http://dx.doi.org/10.3390/jcm9051448 |
Ejemplares similares
-
Fetal Biometric Assessment and Infant Developmental Prognosis of the Tadalafil Treatment for Fetal Growth Restriction
por: Tsuji, Makoto, et al.
Publicado: (2023) -
Tadalafil Treatment Ameliorates Hypoxia and Alters Placental Expression of Proteins Downstream of mTOR Signaling in Fetal Growth Restriction
por: Tsuchiya, Kyoka, et al.
Publicado: (2020) -
Maternal Blood Concentration of Tadalafil and Uterine Blood Flow in Pregnancy
por: Tanaka, Hiroaki, et al.
Publicado: (2019) -
Placental growth factor level is correlated with intrapartum fetal heart rate findings
por: Tanaka, Hiroaki, et al.
Publicado: (2022) -
Accurate evaluation of the progress of delivery with transperineal ultrasound may improve vaginal delivery: a single-center retrospective study
por: Enomoto, Naosuke, et al.
Publicado: (2023)